European Commission approves Kimberly-Clark's $40 billion acquisition of Kenvue
The European Commission has granted approval for Kimberly-Clark's $40 billion acquisition of Kenvue, the maker of Tylenol, after the Kleenex and Huggies manufacturer offered concessions to address EU antitrust concerns about competition.
